LASR

Analyst Note: LASR (nLIGHT, Inc.)

Date: 2026-06-13 Current Price: $64.73

1. Structural Readiness

• State: Context-Only (Forming Coil)
• Conservative Entry: Not yet defined (awaiting breakout confirmation).
• Aggressive/Pre-Breakout Entry: Not applicable for a confirmed trade; currently observing the formation.
• Breakout Level: Not yet fired.
• Current Price: $64.73.
• Extension: Not applicable (price is within the consolidation range, not extended above a breakout).
• ATR Context: Current ATR is 9.0% (Extreme). This indicates elevated volatility, which increases the risk of whipsaws during the formation phase and requires careful position sizing if a pre-breakout position were to be considered.

2. Thesis Layer

• Primary Secular Thesis: Defense Modernization (C4ISR / Sensors / EW).
• Role & Directness: nLIGHT is a direct beneficiary and primary technology provider for the U.S. government's Directed Energy (DE) initiatives. The company supplies high-power lasers essential for mission-critical directed energy systems, optical sensing, and advanced manufacturing.
• Thesis Weighting: The company is a "Tier 2" exposure within the Defense Modernization theme. The thesis is strengthened by the specific alignment of nLIGHT's product roadmap (1-megawatt CBC high energy laser) with the U.S. government's budgeted procurement for 2027 and 2028. The secular tailwind is driven by the strategic necessity for scalable, low-cost-per-shot solutions to counter evolving threats, a narrative explicitly reinforced by management in recent earnings calls.

3. Business Overview

nLIGHT, Inc. operates as a leading provider of high-power lasers for mission-critical applications, serving three primary end markets: Aerospace and Defense, Industrial, and Microfabrication.

• Business Model: The company utilizes a dual distribution approach, leveraging a direct sales force in key markets (U.S., China, South Korea, Europe) and partnering with independent representatives for wider regions. Operations are divided into "Laser Products" and "Advanced Development" segments.
• Key Evidence (as of 2026-06-13):
• Revenue Growth: Q1 2026 revenue was $80 million, up 55% year-over-year. Aerospace and Defense (A&D) revenue specifically grew 69% year-over-year to $55 million, driven by a 98% year-over-year increase in A&D products revenue.
• Backlog & Visibility: As of December 31, 2025, the backlog totaled $161.6 million, with all backlog expected to be filled within the next 24 months. Additionally, the unfunded value of government contracts stood at $184.4 million as of that date.
• Program Specifics: Management confirmed they are on track with the production of the 1-megawatt CBC high energy laser for the HELSI-2 program.
• Budget Alignment: Management noted that nearly $400 million is budgeted in each of the 2027 and 2028 fiscal years for Directed Energy prototypes and procurement, with the overall annual budget for DE laser weapons increasing to approximately $1 billion in those years.
• Margins: The increase in products gross margin for Q1 2026 was driven by sales mix and the impact of increased production volumes on fixed manufacturing costs.
• Liquidity: As of March 31, 2026, $20.0 million was outstanding on the Line of Credit (LOC), with the company in compliance with all covenants. Management expects existing liquidity sources to be sufficient for working capital and capex needs for at least the next 12 months.

4. Archetype and Conviction

• Archetype: Margin Inflector / Growth Leader.
• Fit Analysis: The company fits the "Margin Inflector" archetype as it transitions from development to high-volume production. Evidence [E12] explicitly attributes margin expansion to "sales mix and the impact of increased production volumes on fixed manufacturing costs." This suggests the company is leveraging its scale to improve profitability as it ramps up delivery of high-value defense contracts.
• Valuation Context: The financial spine indicates a forward consensus EPS of $0.52444 for FY1 and $0.67556 for FY2.
• Conviction Stack:
• Thesis Strength: High. The alignment with the $1 billion annual DE budget and specific $400M procurement lines provides a clear secular tailwind.
• Evidence Quality: Strong. Recent earnings (May 2026) and filings (Feb/May 2026) provide concrete figures on backlog, revenue growth, and program status.
• Structural Quality: Moderate to High. The backlog covers the next 24 months, and the company is on track with major program milestones.
• Rerating Potential: Significant, contingent on the successful delivery of the 1-megawatt laser and the realization of the 2027/2028 budgeted procurement.

5. Invalidations, Strengths, and Gaps

• Invalidation Triggers:
• A significant delay or cancellation of the HELSI-2 program or the 1-megawatt laser production.
• A breach of LOC covenants or a liquidity shortfall (though management currently expects sufficiency for 12 months).
• Strengthening Factors:
• Confirmation of the 2027/2028 budgeted procurement awards.
• Further sequential growth in A&D markets as guided for Q2 2026.
• Continued expansion of gross margins driven by volume.
• Evidence Gaps:
• Specific Contract Values: While the backlog and unfunded contract values are known, the specific dollar value of individual contracts awarded in the 2027/2028 window is not detailed in the provided evidence, only the aggregate budget.
• Q2 2026 Actuals: The evidence provides guidance for Q2 2026 ($75M-$81M) but does not yet contain the actual reported results for that quarter as of the event date (June 13, 2026), leaving a small window of unverified performance.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: $161.6M backlog with 100% fill rate expected within 24 months; Q1 A&D revenue up 98% YoY; Management confirms on-track status for 1-megawatt HELSI-2 laser. Key risks: Extreme ATR (9.0%) indicates high volatility and potential for false breakouts; Heavy reliance on U.S. government budget execution and timing; Liquidity constraints if production ramp exceeds cash flow expectations. Sizing hint: Position size should be reduced relative to a confirmed breakout due to the "Forming" state and extreme volatility; treat as a watch-list entry pending structural confirmation. Expected path: Management expects sequential A&D growth in Q2 2026; if the 1-megawatt laser production remains on track, the company should continue to leverage fixed cost dilution to expand margins. Expected horizon: 12 to 24 months for the backlog to convert and for the 2027/2028 budget cycles to materialize into revenue.